Companies / Brazil
If you would like to subscribe to Americas Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Americas Pharma & Healthcare Insight please click on the trial link below.
Aspen Takes Control Of Strides Latina
September 2008 | Company News AlertSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Americas Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Americas Pharma & Healthcare Insight please click on the trial link below.
In the face of disappointing financial results, India's Strides Arcolab has agreed to the sale of its Latin America joint venture, Strides Latina, to its partner, South Africa's Aspen Pharmacare. Aspen is to initially acquire a 1% stake in the former 50:50 joint venture for US$2.8mn, giving it managerial control of the operation through its wholly owned subsidiary, Aspen Global. Strides also plans to sell the remaining 49% to Aspen, based on Strides Latina's financial performance in the year to June 2009. The maximum value of the deal would be US$333.5mn if Strides Latina were to achieve an EBITDA of